Therapeutic options in coronary artery disease: Focusing on the guidelines

Canadian Journal of Cardiology

Volumn 25, Issue 1, 2009, Pages 19-24

  Schwartz, Leonard ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Angina; Coronary artery bypass; Guidelines; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

FIBRINOLYTIC AGENT;

ANGIOCARDIOGRAPHY; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DOSE RESPONSE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; ST SEGMENT ELEVATION; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 60849130708     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70018-2     Document Type: Article

References (34)

1. Goldman BS. The life and hard times of a coronary surgeon. Can J Cardiol 2007;23:183-8.
2. Heberden W. Some accounts of a disorder of the breast. Read before the College of Physicians July 21, 1768. M.Tr/Roy College Physicians, London 1772;2:59.
3. Lin GA, Dudley RA, Redberg RF. Cardiologists' use of percutaneous coronary interventions for stable angina. Arch Intern Med 2007;167:1604-9.
4. Overgaard CB, Schwartz L. The accuracy of non-invasive imaging for coronary artery disease in clinical practice. Can J Cardiol 2007;23:890. (Abst)
5. Antman EM, Hand M. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 1998;51:210-47.
6. Eagle K, Guyton RA. ACC/AHA guidelines on coronary artery bypass graft surgery. J Am Coll Cardiol 2004;44:1146-54.
7. Antman EM, Smith SC. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Can J Cardiol 2004;20:977-1025.
8. Wijeysundera HC, Vijayarghavan R, Nallamouthu BK, et al. Rescue angioplasty or repeat fibrinolyisis after failed fibrinolytic therapy for ST-segment myocardial infarction: A meta-analysis of randomized trials. J Am Coll Cardiol 2007;49:422-30.
9. Primary vs tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomized trial. Lancet 2006;367:569-78.
10. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomised controlled trial. Lancet 2004;364:1045-53.
11. Zeymer U, Uebis R, Vogt A, et al. Randomized comparison of percutaneous coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: A study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte. Circulation 2003;108:1324-28.
12. Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006;355:2395-407.
13. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
14. Anderson JL. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction - executive summary. J Am Coll Cardiol 2007;50:652-726.
15. FRagmin and fast revascularization during InStability in Coronary artery disease investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease. FRISC-II prospective randomized multicentre study. Lancet 1999;354:708-15.
16. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-16.
17. Neumann FJ, Kastrati A, Pogastsa-Murray G, et al. Evaluation of the prolonged antithrombotic pretreatment ("cooling off" strategy) before intervention in patients with unstable syndromes: A randomized controlled trial. JAMA 2003;290:1593-9.
18. Tricoci P, Lokhnygina Y, Berdan LG, et al. Time to coronary angiography and outcomes among patients with high risk non-ST-segment-elevation acute coronary syndromes: Results from the SYNERGY Trial. Circulation 2007;116:2669-77.
19. Smith SC. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention - summary article. J Am Coll Cardiol 2006;47:216-35.
20. Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ. Revisiting the culprit lesion in non-Q wave myocardial infarction: Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 2002;39:1456-63.
21. de Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 1995;92:1408-13.
22. Nissen SE, Yock P. Intravascular ultrasound: Novel diagnostic insights and current clinical applications. Circulation 2001;103:604-16.
23. Nissen SE. Pathobiology, not angiography should guide management of acute coronary syndrome/non-ST elevation myocardial infarction. J Am Coll Cardiol 2003;41:103S-12S.
24. Bourassa MG, Kip KE, Jacobs AK, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery. J Am Coll Cardiol 1999;33:1627-36.
25. Ong ATL, Serruys PW. Complete revascularization. Coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation 2006;114:249-55.
26. Scrinivas SV, Selzer F, Wilensky RL, et al. Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome. A report from the NHLBI dynamic registry. J Interven Cardiol 2007;20:373-80.
27. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.
28. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006;113:2406-12.
29. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary artery bypass grafting in multivessel coronary disease. N Engl J Med 358:331-41.
30. Valgimigle M, Dawkins K, Macaja C, et al. Impact of stable and unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents. A subanalysis of the ARTS-II trial. J Am Coll Cardiol 2007;49:431-44.
31. Winstein KJ. Bypasses outshine stents in study; patients fared better by choosing surgery for multiple blockages. Wall Street Journal. January 24, 2008:D.6.
32. Centers for Disease Control and Prevention. Prevalence of heart disease. MMWR Surveill Summ 2007;56:113-8.
33. Chow C-M, Donovan L, Manuel D, Johansen H, Tu JV. Regional variation in self-reported heart disease prevalence in Canada. Can J Cardiol 2005;21:1265-71.
34. Faris PD, Grant FC, Galbraith PD, Gong Y, Ghali WA. Diagnostic cardiac catheterization and revascularization rates for coronary heart disease. Can J Cardiol 2004;20:391-7.